胃肠道患者进食障碍（包括 ARFID）的识别和管理。
Identification and Management of Eating Disorders (including ARFID) in GI Patients.
机构信息
Division of Gastroenterology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA; Harvard Medical School, 25 Shattuck St, Boston, MA 02115, USA; Department of Psychiatry, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.
Division of Gastroenterology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.
出版信息
Gastroenterol Clin North Am. 2022 Dec;51(4):765-783. doi: 10.1016/j.gtc.2022.07.004. Epub 2022 Oct 22.
Eating disorders are characterized by cognitions (eg, fear of gastrointestinal symptoms around eating, overvaluation of body shape/weight) and behaviors (eg, dietary restriction, binge eating) associated with medical (eg, weight loss), and/or psychosocial impairments (eg, high distress around eating). With growing evidence for bidirectional relationships between eating disorders and gastrointestinal disorders, gastroenterology providers' awareness of historical, concurrent, and potential risk for eating disorders is imperative. In this conceptual review, we highlight risk and maintenance pathways in the eating disorder-gastrointestinal disorder intersection, delineate different types of eating disorders, and provide recommendations for the gastroenterology provider in assessing and preventing eating disorder symptoms..
进食障碍的特征为认知（例如，进食时害怕胃肠道症状、对体型/体重的过度重视）和行为（例如，饮食限制、暴食），这些与医学（例如，体重减轻）和/或心理社会损伤（例如，进食时高度痛苦）有关。越来越多的证据表明进食障碍和胃肠道疾病之间存在双向关系，因此，胃肠病学提供者必须意识到进食障碍的历史、同时存在和潜在风险。在本概念综述中，我们强调了进食障碍-胃肠道疾病交叉点的风险和维持途径，描述了不同类型的进食障碍，并为胃肠病学提供者在评估和预防进食障碍症状方面提供了建议。
Zotero 插件